According to this latest study, the 2021 growth of Next-Generation Breast Cancer Diagnostic and Screening will have significant change from previous year. By the most conservative estimates of global Next-Generation Breast Cancer Diagnostic and Screening market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Next-Generation Breast Cancer Diagnostic and Screening market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Breast Cancer Diagnostic and Screening market by product type, application, key players and key regions and countries.

Segmentation by technology: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Real-Time PCR (q-PCR)

Immunohistochemistry (IHC)

Next-Generation Sequencing (NGS)

Fluorescent In-Situ Hybridization (FISH)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Hospital-associated Labs

Cancer Research Institutes

Diagnostic Centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Abbott Laboratories

Agendia

Agilent Technologies

Ambry Genetics

Biocept

Biotheranostics

Centogene

Danaher Corporation

EXACT Sciences Corporation

Roche Holding AG

Fulgent Genetics

Illumina

Invitae

Lucence Diagnostics Pte Ltd

Myriad Genetics

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size 2016-2026

2.1.2 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Next-Generation Breast Cancer Diagnostic and Screening Segment by Technology

2.2.1 Real-Time PCR (q-PCR)

2.2.2 Real-Time PCR (q-PCR)

2.2.3 Next-Generation Sequencing (NGS)

2.2.4 Fluorescent In-Situ Hybridization (FISH)

2.3 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology

2.3.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Technology

2.3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology (2016-2021)

2.4 Next-Generation Breast Cancer Diagnostic and Screening Segment by Application

2.4.1 Hospital-associated Labs

2.4.2 Cancer Research Institutes

2.4.3 Diagnostic Centers

2.5 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application

2.5.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application

2.5.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2016-2021)

3 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Players

3.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Players

3.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2019-2021E)

3.1.2 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Players (2019-2021E)

3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Next-Generation Breast Cancer Diagnostic and Screening by Regions

4.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions (2016-2021)

4.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2016-2021)

4.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2016-2021)

4.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2016-2021)

4.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2016-2021)

5 Americas

5.1 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2016-2021)

5.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021)

5.3 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2016-2021)

6.2 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021)

6.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Next-Generation Breast Cancer Diagnostic and Screening by Country (2016-2021)

7.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021)

7.3 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening by Region (2016-2021)

8.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021)

8.3 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2021-2026)

10.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2021-2026)

10.1.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.1.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.1.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.1.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast by Countries (2021-2026)

10.2.1 United States Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.2.2 Canada Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.2.3 Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.2.4 Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2021-2026)

10.3.1 China Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.2 Japan Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.3 Korea Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.4 Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.5 India Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.6 Australia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast by Country (2021-2026)

10.4.1 Germany Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.2 France Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.3 UK Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.4 Italy Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.5 Russia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2021-2026)

10.5.1 Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.2 South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.3 Israel Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.4 Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.5 GCC Countries Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.6 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Technology (2021-2026)

10.7 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Information

11.1.2 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Abbott Laboratories Main Business Overview

11.1.5 Abbott Laboratories Latest Developments

11.2 Agendia

11.2.1 Agendia Company Information

11.2.2 Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Agendia Main Business Overview

11.2.5 Agendia Latest Developments

11.3 Agilent Technologies

11.3.1 Agilent Technologies Company Information

11.3.2 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Agilent Technologies Main Business Overview

11.3.5 Agilent Technologies Latest Developments

11.4 Ambry Genetics

11.4.1 Ambry Genetics Company Information

11.4.2 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Ambry Genetics Main Business Overview

11.4.5 Ambry Genetics Latest Developments

11.5 Biocept

11.5.1 Biocept Company Information

11.5.2 Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Biocept Main Business Overview

11.5.5 Biocept Latest Developments

11.6 Biotheranostics

11.6.1 Biotheranostics Company Information

11.6.2 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Biotheranostics Main Business Overview

11.6.5 Biotheranostics Latest Developments

11.7 Centogene

11.7.1 Centogene Company Information

11.7.2 Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Centogene Main Business Overview

11.7.5 Centogene Latest Developments

11.8 Danaher Corporation

11.8.1 Danaher Corporation Company Information

11.8.2 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Danaher Corporation Main Business Overview

11.8.5 Danaher Corporation Latest Developments

11.9 EXACT Sciences Corporation

11.9.1 EXACT Sciences Corporation Company Information

11.9.2 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 EXACT Sciences Corporation Main Business Overview

11.9.5 EXACT Sciences Corporation Latest Developments

11.10 Roche Holding AG

11.10.1 Roche Holding AG Company Information

11.10.2 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Roche Holding AG Main Business Overview

11.10.5 Roche Holding AG Latest Developments

11. Fulgent Genetics

11.11.1 Fulgent Genetics Company Information

11.11.2 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.11.3 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Fulgent Genetics Main Business Overview

11.11.5 Fulgent Genetics Latest Developments

11.12 Illumina

11.12.1 Illumina Company Information

11.12.2 Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.12.3 Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Illumina Main Business Overview

11.12.5 Illumina Latest Developments

11.13 Invitae

11.13.1 Invitae Company Information

11.13.2 Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.13.3 Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Invitae Main Business Overview

11.13.5 Invitae Latest Developments

11.14 Lucence Diagnostics Pte Ltd

11.14.1 Lucence Diagnostics Pte Ltd Company Information

11.14.2 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.14.3 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Lucence Diagnostics Pte Ltd Main Business Overview

11.14.5 Lucence Diagnostics Pte Ltd Latest Developments

11.15 Myriad Genetics

11.15.1 Myriad Genetics Company Information

11.15.2 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.15.3 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Myriad Genetics Main Business Overview

11.15.5 Myriad Genetics Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Real-Time PCR (q-PCR)

Table 3. Major Players of Immunohistochemistry (IHC)

Table 4. Major Players of Next-Generation Sequencing (NGS)

Table 5. Major Players of Fluorescent In-Situ Hybridization (FISH)

Table 6. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Technology (2020-2026) & ($ Millions)

Table 7. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021) & ($ Millions)

Table 8. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology (2016-2021)

Table 9. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 10. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021) & ($ Millions)

Table 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2016-2021)

Table 12. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2019-2021E) & ($ Millions)

Table 13. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Players (2019-2021E)

Table 14. Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered

Table 15. Next-Generation Breast Cancer Diagnostic and Screening Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions 2016-2021 & ($ Millions)

Table 19. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions 2016-2021

Table 20. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2016-2021) & ($ Millions)

Table 21. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2016-2021)

Table 22. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021) & ($ Millions)

Table 23. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology (2016-2021)

Table 24. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021) & ($ Millions)

Table 25. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2016-2021)

Table 26. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2016-2021) & ($ Millions)

Table 27. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2016-2021)

Table 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021) & ($ Millions)

Table 29. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology (2016-2021)

Table 30. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021) & ($ Millions)

Table 31. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2016-2021)

Table 32. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2016-2021) & ($ Millions)

Table 33. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2016-2021)

Table 34. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021) & ($ Millions)

Table 35. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology (2016-2021)

Table 36. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021) & ($ Millions)

Table 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2016-2021)

Table 38. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2016-2021)

Table 40. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Technology (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology (2016-2021)

Table 42. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2016-2021)

Table 44. Key and Potential Regions of Next-Generation Breast Cancer Diagnostic and Screening

Table 45. Key Application and Potential Industries of Next-Generation Breast Cancer Diagnostic and Screening

Table 46. Key Challenges of Next-Generation Breast Cancer Diagnostic and Screening

Table 47. Key Trends of Next-Generation Breast Cancer Diagnostic and Screening

Table 48. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 49. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Regions (2021-2026)

Table 50. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Technology (2021-2026) & ($ Millions)

Table 51. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Technology (2021-2026)

Table 52. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 53. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Application (2021-2026)

Table 54. Abbott Laboratories Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 55. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 56. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 57. Abbott Laboratories Main Business

Table 58. Abbott Laboratories Latest Developments

Table 59. Agendia Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 60. Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 61. Agendia Main Business

Table 62. Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. Agendia Latest Developments

Table 64. Agilent Technologies Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 65. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 66. Agilent Technologies Main Business

Table 67. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 68. Agilent Technologies Latest Developments

Table 69. Ambry Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 70. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 71. Ambry Genetics Main Business

Table 72. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 73. Ambry Genetics Latest Developments

Table 74. Biocept Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 75. Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 76. Biocept Main Business

Table 77. Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 78. Biocept Latest Developments

Table 79. Biotheranostics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 80. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 81. Biotheranostics Main Business

Table 82. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 83. Biotheranostics Latest Developments

Table 84. Centogene Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 85. Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 86. Centogene Main Business

Table 87. Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 88. Centogene Latest Developments

Table 89. Danaher Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 90. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 91. Danaher Corporation Main Business

Table 92. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 93. Danaher Corporation Latest Developments

Table 94. EXACT Sciences Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 95. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 96. EXACT Sciences Corporation Main Business

Table 97. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 98. EXACT Sciences Corporation Latest Developments

Table 99. Roche Holding AG Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 100. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 101. Roche Holding AG Main Business

Table 102. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 103. Roche Holding AG Latest Developments

Table 104. Fulgent Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 105. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 106. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 107. Fulgent Genetics Main Business

Table 108. Fulgent Genetics Latest Developments

Table 109. Illumina Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 110. Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 111. Illumina Main Business

Table 112. Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 113. Illumina Latest Developments

Table 114. Invitae Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 115. Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 116. Invitae Main Business

Table 117. Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 118. Invitae Latest Developments

Table 119. Lucence Diagnostics Pte Ltd Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 120. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 121. Lucence Diagnostics Pte Ltd Main Business

Table 122. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 123. Lucence Diagnostics Pte Ltd Latest Developments

Table 124. Myriad Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 125. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 126. Myriad Genetics Main Business

Table 127. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 128. Myriad Genetics Latest Developments

List of Figures

Figure 1. Next-Generation Breast Cancer Diagnostic and Screening Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology in 2020

Figure 7. Next-Generation Breast Cancer Diagnostic and Screening in Hospital-associated Labs

Figure 8. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Hospital-associated Labs (2016-2021) & ($ Millions)

Figure 9. Next-Generation Breast Cancer Diagnostic and Screening in Cancer Research Institutes

Figure 10. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Cancer Research Institutes (2016-2021) & ($ Millions)

Figure 11. Next-Generation Breast Cancer Diagnostic and Screening in Diagnostic Centers

Figure 12. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Diagnostic Centers (2016-2021) & ($ Millions)

Figure 13. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2020

Figure 14. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Player in 2020

Figure 15. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2016-2021 ($ Millions)

Figure 17. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2016-2021 ($ Millions)

Figure 18. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2016-2021 ($ Millions)

Figure 20. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country in 2020

Figure 21. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology in 2020

Figure 22. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2020

Figure 23. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions in 2020

Figure 27. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology in 2020

Figure 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2020

Figure 29. China Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country in 2020

Figure 36. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology in 2020

Figure 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2020

Figure 38. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Technology in 2020

Figure 45. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2020

Figure 46. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 52. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 53. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 55. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 56. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 59. China Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 60. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 61. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 63. India Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 64. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 65. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 66. France Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 67. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 68. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 69. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 70. Spain Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 73. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country Next-Generation Breast Cancer Diagnostic and Screening Market Size 2021-2026 ($ Millions)